Do you have a cancer that is advanced or metastatic? Has your cancer progressed on other standard of care therapies? If you answered yes, then this research study may be for you. Study drug will be provided

The purpose of this study is to better understand how workers manage the various challenges and opportunities related to making work transitions.

The purpose of this study is to compare the effects of the research medicine, solrikitug, with a placebo to find out which is better for treating eosinophilic esophagitis (EoE) in adult patients. The purpose is to see if the research medicine helps improve EoE symptoms: dysphagia (difficulty swallowing), tissue inflammation, clinical symptoms and quality of life.

In this study, we want to help Black and African American people who have had colon cancer, rectal cancer, or colorectal cancer. We want to see if an exercise program can help with cancer side effects and overall quality of life.

Researchers are collecting data on lung imaging to evaluate how well a person's lungs are working which will provide additional information about lung disease and how such diseases respond to treatment. The purpose of this study is to evaluate the use of inert (non-reactive) gas mixed with oxygen as contrast agent to image the airway spaces in normal human lungs and the lungs of persons with cystic fibrosis. A contrast agent helps the investigator to see spaces inside your lungs that are normally not visible. These images will be compared with spirometry (a non-imaging measure of global lung function used routinely in the clinic).

In this study, we will find out if a new experimental pill called ropidoxuridine can help improve the treatment of a brain cancer called IDH-Wildtype Glioblastoma. We want to see how well it works when used with radiation therapy.

Do you have relapsed peripheral T-cell lymphoma (PTCL)? Has your cancer not gotten better with other treatments, or were those treatments stopped because of bad side effects? If so, you might be able to join a study to see if a new drug called Soquelitinib (also known as CPI-818) can treat PTCL better.

In this study, we are exploring how couples who trying to have a baby get ready to become parents for the first time. We want to understand what they do to prepare before they get pregnant.

This research study explores elementary school professional experiences and perspectives in assessing and intervening in suicide-related risk among K-5th graders.

This study is being carried out to learn more about administration of xaluritamig in people with high-risk biochemical recurrence (BCR) or sometimes referred to as nonmetastatic castration-sensitive prostate cancer (nmCSPC) after receiving definitive (primary) treatment.